Findings

What do systematic reviews say?

7 questions · 7 findings · 1 reviews

No studies found 1 · 14.3%GRADE not reported 0 · 0%Very low 3 · 42.9%Low 3 · 42.9%Moderate 0 · 0%High 0 · 0%

Frequent relapses · SSNS in children

Mycophenolate mofetil showed no clear difference in frequent relapses at 12 months compared with levamisole (low certainty).

1 finding from 1 review

Mean relapse rate/patient/month · SSNS in children

The review found no eligible studies for this question.

1 finding from 1 review

Peritonitis · SSNS in children

It is very uncertain whether mycophenolate mofetil changes adverse effects: peritonitis compared with levamisole (very low certainty).

1 finding from 1 review

Abdominal pain · SSNS in children

Mycophenolate mofetil showed no clear difference in adverse effects: abdominal pain compared with levamisole (low certainty).

1 finding from 1 review

Adverse effects: anaemia · SSNS in children

It is very uncertain whether mycophenolate mofetil changes adverse effects: anaemia compared with levamisole (very low certainty).

1 finding from 1 review

Adverse effects: leukopenia · SSNS in children

It is very uncertain whether mycophenolate mofetil changes adverse effects: leukopenia compared with levamisole (very low certainty).

1 finding from 1 review

Relapse · SSNS in children

Mycophenolate mofetil showed no clear difference in relapses at 12 months compared with levamisole (low certainty).

1 finding from 1 review